NCT01830595View on ClinicalTrials.gov

Lactoferrin Treatment in HIV Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

January 31, 2018

Conditions

HIV Infection

Interventions

DRUG

Recombinant Lactoferrin

DRUG

Placebo

Trial Locations (1)

55415

Hennepin County Medical Center, Minneapolis

Sponsors

Collaborators (1)

Ventria Bioscience

All Listed Sponsors

collaborator

Ventria Bioscience

INDUSTRY

lead

Jason Baker

OTHER

NCT01830595 - Lactoferrin Treatment in HIV Patients | Biotech Hunter | Biotech Hunter